Risk of Kawasaki Disease/Multisystem Inflammatory Syndrome Following COVID-19 Vaccination in Korean Children: A Self-Controlled Case Series Study
The results of this nationwide study suggest that the risk of developing KD/MIS-C did not increase after COVID-19 vaccination. However, owing to the lack of a sufficient number of cases, future studies utilizing multinational long-term follow-up databases should be conducted. Considering the increasing incidence of KD/MIS-C and the limited understanding of its precise biological mechanisms, additional research on KD/MIS-C is warranted.
Authors
- Ju Hwan Kim (ORCID: https://orcid.org/0000-0001-7253-6515)
- Ju‐Young Shin (ORCID: https://orcid.org/0000-0003-1010-7525)
- Dongwon Yoon (ORCID: https://orcid.org/0000-0002-9369-0789)
- Young June Choe (ORCID: https://orcid.org/0000-0003-2733-0715)
- Hwa Yeon Ko (ORCID: https://orcid.org/0000-0001-5297-8826)
- Suyeon Kim (ORCID: https://orcid.org/0009-0009-9364-3665)
- J. Oh (ORCID: https://orcid.org/0009-0000-6779-0957)
Institutions
- Samsung (South Korea) (KR)
- Korea University Medical Center (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Journal of Korean Medical Science
- Published
- 2024-11-05
- DOI
- https://doi.org/10.3346/jkms.2025.40.e10
- Primary Topic
- Kawasaki Disease and Coronary Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Korea Disease Control and Prevention Agency
- National Research Foundation
- Ministry of Food and Drug Safety
- National Research Foundation of Korea
- LG Chem